
|

Information for Journalists
Corporate Information
Digene-QIAGEN Merger |
Digene has now merged with QIAGEN to create one, combined company that will be a market and technology leader in molecular diagnostics. The content of this Web site will soon be transferred to QIAGEN.com for corporate information and to theHPVtest.com for HPV/HPV testing information.
Read the news release announcing the finalization of the merger.
|
HPV Test Information
Flash Diagram |
|
For an illustration of how providing the HPV test along with a Pap benefits women and cervical cancer screening programs, click "play".
|
Click on the link to view an enlarged image.
High–resolution photos and logos are available upon request. Contact Shelley Ducker or Pam Rasmussen at 301.944-7610/7196 or e-mail corporate.communications@digene.com
Please include the following notation(s) when using Digene logos in your materials: Digene®, hc2 High-Risk HPV DNA Test® and Hybrid Capture® are registered trademarks of Digene Corporation. DNAwithPap® is a trademark of Digene Corporation.
For additional information or inquiries on the Newsroom, call Pam Rasmussen or Shelley Ducker at 301-944-7196/7610 or e-mail corporate.communications@digene.com
back to top
|